![CancerX Moonshot’s new resources provide patient navigators with the tools they need to develop a business case](https://oncodaily.com/pub/uploads/2024/08/1724774582654.jpg)
CancerX Moonshot’s new resources provide patient navigators with the tools they need to develop a business case
CancerX Moonshot shared on LinkedIn:
“During a public launch event today, CancerX launched the final set of resources from the “Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research” project – a Digital Navigation ROI Calculator and a Digitally Enabled Patient Navigation Blueprint.
Financial toxicity risk after a cancer diagnosis is unevenly spread. Certain patient populations face unnecessary barriers in accessing specialized cancer treatment and disparities in clinical outcomes, such as higher mortality rates. Patient navigation programs enhance equal access to care, diminish financial toxicity, and improve health and quality of life outcomes. However, they are not currently implemented at scale due to resource constraints.
CancerX’s new, free resources provide patient navigators with the tools they need to develop a business case and implementation strategy for standardized, scalable, and sustainable patient navigation programming. Put these resources into action today:
Use the Digital Navigation ROI Calculator to demonstrate the ROI your system may accrue after investing in digital patient navigation to boost access and reduce financial toxicity.
Use the Digitally Enabled Patient Navigation Blueprint to ensure your patient navigation programming is standardized, efficient, and reimbursable. It also helps you build the business case for using digital patient navigation that improves access to care and reduces patient financial toxicity.
The resources prove the value of investing in digital navigation programming to reduce patient financial toxicity, which impacts consistent appointment attendance, treatment plan adherence, access to necessary medications, and, ultimately, survival outcomes.
Access the resources.”
Source: CancerX Moonshot/LinkedIn